Get Permission Malarvizhi R, Anuradha A, Latha KST, and Kumar: A clinical study on prevalence and management of eyelid tumours – A prospective observational study


Introduction

Eyelid lesions are categorised into inflammatory, infectious and neoplastic. Among tumours encountered by ophthalmologist, most common neoplasms are those of eyelids. Lid reconstruction is often essential for tissue loss after wide excision of lid tumors. The process of decision making is mentioned in Figure 1. In a study by Jangir et al,1 the most common benign tumour included epidermal cyst (21.3%), demoid cyst (13.89%), intradermal naevus (12.03%) and haemangioma (12.03%) in western parts of the country. A study by Kaliki et al showed sebaceous gland carcinoma to be most common malignant tumor (53%) followed by basal cell carcinoma (24%) in India.2  This study is to evaluate the incidence, mode of onset, various clinical presentations of lid tumours. The various treatment options and the final functional and cosmetic outcome of treatment were also assessed.

Materials and Methods

A prospective observational study conducted at Orbit & Oculoplasty Department, Regional Institute of Ophthalmology, Egmore, Chennai for a period of 1 year after obtaining ethical clearance from the institutional ethical committee. All patients with benign and malignant eyelid tumours were included and those with other inflammatory lesions were excluded.

 Detailed history including the onset, duration, progression, associated features such as pain, discharge or bleeding from the lesion, site of involvement, history of comorbidities, past history of medical and surgical treatment were noted. Ocular examination including size, shape, location, extent, margins of the ulcer/swelling (specific signs of malignancy i.e. eyelid distortion with thickening of lid in sebaceous cell carcinoma, raised rolled out edges with telangiectasia and ulceration in basal cell carcinoma, induration and everted margins in squamous cell carcinoma) and involvement of adjacent lymph node was done. Blood pressure, blood sugar, complete blood count, X-ray chest and X-ray orbit were performed. For larger lesions or if globe/orbital infiltration is suspected, CT/MRI brain and orbit was done. Biopsy either excision or incision was performed for all the cases and sent for histopathological examination after marking the margins to look for involvement. After HPE confirmation of malignant tumours wide local excision with 4-5 mm margin clearance was done. Defect in the eyelid was reconstructed using appropriate reconstruction procedure. Patients with globe and orbital invasion were referred to tumour board and radical procedure like exenteration was done after getting tumour board clearance. Patients who required adjuvant radiotherapy or chemotherapy were referred to the Department of oncology. All patients were followed up at regular intervals to look for tumour recurrence for 1 year. 

Results

Malignant tumours (7 out of 12 malignancies) were commonly seen in the age group between 60-85 years (58.33%) and benign tumours (7 out of 12 malignancies (10 out of 28 benign tumors) were common in the age group of 30-45 years (35.71%) (Figure 2a). Preponderance of benign tumors (57.14%) was observed amng males and malignant tumors (58.33%) preponderance among females (Figure 2b). Out of 40 cases, 28 (70%) were benign and 12  (30%) were malignant (Figure 3) which correlates with a retrospective study by Sha Sha Yu & Xin Tang.3  Benign tumours were found more commonly in the upper lid (75%) and malignant tumours in lower lid (75%) (Figure 4). Squamous papilloma (7 cases) was found to be the most common benign tumour in this study (25%) (Figure 5a) and this was followed by pyogenic granuloma (5 cases - 17.85%). Sebaceous carcinoma (7 out of 12 malignancies i.e. 58.33%) is the most common malignant tumour unlike in the study by Deprez and Uffer 4 which reported that basal cell carcinoma accounted for 86% of all malignant tumors (Figure 5b). Most common presentation of malignant eyelid tumours was in the form of ulcerative growth pattern (6 out of 12 malignancies i.e. p50%) (Figure 6). In our study both ulcer and nodular pattern is seen in case of BCC. Sebaceous adeno-carcinoma of meibomian gland presented in the form of nodule and ulcerative growth pattern. In our study tumour invasion of the globe was most common in case of sebaceous adenocarcinoma of meibomian gland (3 out of 12 malignant cases i.e. 25%). Lymph node metastasis is most commonly found in sebaceous gland carcinoma (4 out of 7 i.e. 57.14%). The treatment for most of the benign tumour was simple excision and the excised tissue was sent for histopathological examination. In our study one case of capillary hemangioma was managed with  systemic and topical beta blockers. The child was started on oral propranolol 1 mg/kg body weight and 0.5% timolol eye drops twice a day after obtaining consensus from paediatrician and cardiologist. Child was reviewed once in three months by ophthalmologist and paediatrician. The lesion started regressing after 4 months of treatment and the treatment was continued with periodic review. Marginal shave excision was done for 5 cases of pyogenic granuloma. In all malignant tumours wide local excision with 4-5mm margins (Figure 7). The excised lesion margins are labelled with markers and sutures and sent for histopathological examination. Glabellar rotation flap was performed in one case of meibomian carcinoma involving the medial aspect of lower lid after the excision of the tumour. Hughes tarso-conjunctival flap was performed in two cases of squamous cell carcinoma (Figure 8a,b) and basal cell carcinoma, after tumour excision as the defect involved more than 75% of the lower lid without involvement of canthus. Two cases, one each of sebaceous carcinoma and squamous cell carcinoma involving the lateral aspect of lower lid was repaired after excision, with Tenzel lateral advancement flap (Figure 9a,b). In one case of sebaceous gland carcinoma with diffuse thickening of whole of the upper lid the tumor was excised and the defect closed with Cutler-Beard technique (Figure 10a,b).  After 2 months secondary reconstruction was done. One case of basal cell carcinoma managed with tumour excision and Fricke’s flap with chondro-mucosal graft elsewhere reported to us with recurrence of tumour. She was advised exenteration as she presented with orbital infiltration of the tumour. As the patient was not willing for surgery radiotherapy was given as suggested by oncologist. 2 cases of sebaceous cell carcinoma and one case of basal cell carcinoma with orbital infiltration underwent orbital exenteration.  One case of advanced sebaceous gland carcinoma who presented to us with infiltration of globe and orbit was advised exenteration as the primary procedure. The patient was not willing for surgery and lost to follow up after that. 

Chart 1

Algorithm for management of lid tumors

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage1.png

Graph 1

Demographics of study population

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage2.png
Graph 2

Incidence: Benign vs Malignant

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage3.png
Graph 3

Lid involvement

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage4.png
Graph 4

Distribution of types of malignancies

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/8b2c3525-b9ee-487b-8e2e-8be42ae0a284/image/ff72778d-dbbd-4d53-91e2-c9adfba9e1c2-u1.png
Graph 5

Morphological patterns of tumors

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage6.png
Graph 6

Modes of managing malignancies

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage7.png
Figure 1

a: Squamous cell carcinoma of lower lid before lid reconstruction; b: After lid reconstruction with Hughes flap reconstruction.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage8.png

Figure 2

a: and b: Managed with Tenzel lateral advancement flap

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage9.png

Figure 3

a and b: Intraoperative pictures of Cutler-Beard Technique

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/a9d13372-ffae-4ce2-8502-9147c2bdf7edimage10.png

Discussion

In our study 40 patients with eyelid lesions were analysed. Out of which 28 patients (70%) had benign and 12  patients (30%) had malignant lesions. This is comparable with a study by Rathod et al 5 where among 100 cases of eyelid tumours 61 were found to be benign and 39 were malignant. Age of the patients with benign lesions were in the range of 30-60yrs and malignant were between 35-80yrs. A case of 36 year old young female patient presented with sebaceous cell carcinoma and 86year old elderly patient was diagnosed with basal cell carcinoma. A study by Kale (2012) et al6 from India observed that the mean age of presentation of malignant eye tumours was 59 years which is in accordance with our study. In our study, the malignant tumour incidence was more in female patients and benign tumours were most commonly found in male patients. In a study by Gosai et al,7 120 cases with eyelid lesions were studied and found that the male to female   ratio was 1.4:1 for benign tumours whereas females outnumbered males with ratio of 1.16:1 for malignant tumours which correlated with our study Out of 30% of malignant tumours, Sebaceous gland carcinoma is the most common accounted for 58.33%. Basal cell carcinoma is the second most common accounted for 25%. This is similar to the studies done by Krishnamurthy et al8 and Mamtani et al9 which found higher incidence (30-40%) of sebaceous gland carcinoma in India. Among Benign eyelid tumours squamous papilloma is the most common tumour in our study and this is comparable to the studies by Ni et al 10 from China observed that squamous papilloma is the most common benign eyelid tumour. Increased incidence of papilloma was also observed in studies conducted by Gundogan et al11   and Deprez and Uffer's.4 The most common presentation of malignant tumours of the upper eyelid was in the form of ulcerative growth. Majority of sebaceous gland carcinoma presented in the form of ulcerative growth and nodule. A study by Syed Ali Raza Rizvi et al12 found that that most common clinical presentation of SGC was a nodular mass lesion. In this study, the most common site of malignant tumour was lower lid. This corroborates with the studies by A Bagheri et al13 and Mary Ho et al14 where they found lower lid to be the most common site of malignant tumours. Studies by Kale et al,13 Suresh Saquil et al15 and various other studies have reported greater occurrence of sebaceous cell carcinoma in the upper eyelid. However in our study lower lid was most commonly involved in sebaceous carcinoma. In Basal cell carcinoma, intraocular invasion is rare but orbit involvement may occur. Metastasis is rare in BCC and mortality is also less. In our study there was one case of basal cell carcinoma with orbital involvement and without globe infiltration. Most of the malignant tumours in our study was managed by tumour excision with 5 mm surgical clearance and the full thickness defect was reconstructed with appropriate flap techniques. Standard Surgical Excision (SSE) of tumour free margin of 4 mm recommended for Basal cell carcinoma and for squamous cell carcinoma it is 4 mm to 6 mm. In our study, procedures like Hughes tarso conjunctival flap for lower eyelid defect, Cutler-Beard two stage procedure for upper eyelid defect were performed when the defect was large (> 50% lid involvement). In a study by Gündüz et al,16 lid sharing procedure was preferred for defects more than 50% and Tenzel flaps for defects between 25 – 50%.  

Conclusion

Histopathologic examination of all excised lesion involving the lid must be done as an innocuous looking lesion might be malignant. Early clinical diagnosis of malignant tumours with confirmation by incision biopsy, will aid in complete wide excision of tumour After wide excision of malignant tumour appropriate lid reconstruction technique is done as a primary procedure in all our patients and we could obtain good outcomes with no recurrences. Complete eyelid reconstruction requires through knowledge of several techniques and their range of applicability. The ideal goal of reconstruction is to restore physiological functioning of eyelid with respect to vision, lid closure, mobility and tear drainage and to re-establish anatomic integrity to provide better cosmetic appearance. Advanced tumours with orbital involvement and recurrent tumours will need adjuvant chemotherapy and radiotherapy.  

Limitations of the Study

Small sample size and difficulty in follow up.

Conflict of Interest

The authors declare that there are no conflicts of interest in this paper.

Source of Funding

None.

References

1 

M K Jangir A Kochar N A Khan M Jaju Profile of Eyelid Tumours: Histopathological Examination and Relative Frequency At A Tertiary Centre In North-West RajasthanOfficial Sci J Delhi Ophthalmol Soc201728152810.7869/djo.305

2 

S Kaliki N Bothra K M Bejjanki A Nayak G Ramappa A Mohamed Malignant Eyelid Tumors in India: A Study of 536 Asian Indian PatientsOOP2019532109

3 

SS Yu Y Zhao H Zhao JY Lin X Tang A retrospective study of 2228 cases with eyelid tumorsInt J Ophthalmol20181111183541

4 

M Deprez S Uffer Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literatureAm J Dermatopathol200931325662

5 

A Rathod M Pandharpurkar K Toopalli S Bele A clinicopathological study of eyelid tumours and its management at a tertiary eye care centre of Southern IndiaMRIMS J Health Sci20153154810.4103/2321-7006.301960

6 

S M Kale S B Patil N Khare M Math A Jain S Jaiswal Clinicopathological analysis of eyelid malignancies - A review of 85 casesIndian J Plast Surg2012451228

7 

J Gosai D Mehta K Pherwani R Bhatt K Agrawal D Tandel Clinical Study of Lid Tumors in Adult Patients of Western Region of IndiaJ Evol Med Dent Sci2014373153647310.14260/jemds/2014/4071

8 

H Krishnamurthy V Tanushree HT Venkategowda, S Archana G Mobin A D'Silva Profile of eyelid tumors at tertiary care institute in Karnataka: a 5-years surveyJ Evol Med Dent Sci20143501181832

9 

M Mamtani S Jahagirdar T Thakre S Kale H Kulkarni A clinicopathological study of eyelid malignancies from central IndiaIndian J Ophthalmol20075521091210.4103/0301-4738.30703

10 

Z Ni Histopathological classification of 3,510 cases with eyelid tumorZhonghua Yan Ke Za Zhi19963264357

11 

F C Gundogan U Yolcu A Tas O F Sahin S Uzun H Cermik Eyelid tumors: clinical data from an eye center in Ankara TurkeyAsian Pac J Cancer Prev2015161042659

12 

SA Raza Rizvi MS Alam K Akhtar Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcomeOman J Ophthalmol2018111217

13 

A Bagheri M Tavakoli A Kanaani R B Zavareh H Esfandiari M Aletaha Eyelid masses: a 10-year survey from a tertiary eye hospital in TehranMiddle East Afr J Ophthalmol201320318792

14 

M Ho DTL Liu KKL Chong HK Ng DSC Lam Eyelid tumours and pseudotumours in Hong Kong: a ten-year experienceHong Kong Med J20131921505

15 

S Sagili R Malhotra The importance of considering sebaceous gland carcinoma in presumed chalazia in South Asian patients?Br J Gen Pract2013636077410.3399/bjgp13x663037

16 

K Gündüz S Demirel I Günalp B Polat Surgical approaches used in the reconstruction of the eyelids after excision of malignant tumorsAnn Ophthalmol (Skokie)200638320712



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 12-01-2022

Accepted : 02-02-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijooo.2022.012


Article Metrics






Article Access statistics

Viewed: 1351

PDF Downloaded: 2665